Press Release – New York, NY – April 28, 2025 – Sichenzia Ross Ference Carmel LLP announced today that it represented Lexaria Bioscience Corp. (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, in its $2 million registered direct offering of common stock.
H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.
The SRFC team was led by partners Gregory Sichenzia, Avital Perlman, and Marcelle Balcombe, and associates Soumya Cheedi and Christian Lichtenberger.
